Detection and molecular analysis of circulating tumor cells for early diagnosis of pancreatic cancer

Medical Hypotheses

Volumn 80, Issue 6, 2013, Pages 833-836

  Ren, Chuanli ^a   Chen, Hui ^a   Han, Chongxu ^a   Jin, Guangfu ^b   Wang, Daxin ^a   Wang, Daorong ^a   Tang, Dong ^a  

^a NORTHERN JIANGSU PEOPLE S HOSPITAL   (China)

^b NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; BLOOD; CANCER DIAGNOSIS; CANCER RECURRENCE; CANCER SCREENING; CANCER STAGING; CIRCULATING TUMOR CELL; EARLY CANCER; HUMAN; IN SITU HYBRIDIZATION; MICROFLUIDICS; NONHUMAN; PANCREAS CANCER; TUMOR BIOPSY; TUMOR INVASION;

CELL COUNT; CYTODIAGNOSIS; HUMANS; IN SITU HYBRIDIZATION; MODELS, BIOLOGICAL; NEOPLASTIC CELLS, CIRCULATING; PANCREATIC NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 84877137161     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2013.03.027     Document Type: Article

References (33)

1. Vincent A., Herman J., Schulick R., et al. Pancreatic cancer. Lancet 2011, 378:607-620.
2. Hidalgo M. Pancreatic cancer. N Engl J Med 2010, 362:1605-1617.
3. Cen P., Ni X., Yang J., et al. Circulating tumor cells in the diagnosis and management of pancreatic cancer. Biochim Biophys Acta 2012, 1826:350-356.
4. Zhang L., Riethdorf S., Wu G., et al. Meta-analysis of the prognostic value of circulating tumor cells in breast cancer. Clin Cancer Res 2012, 18:5701-5710.
5. Cristofanilli M., Budd G.T., Ellis M.J., et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351:781-791.
6. Wang X., Sun Q., Mao F., et al. CTCs hemodialysis: can it be a new therapy for breast cancer?. Med Hypotheses 2013, 80:99-101.
7. Campbell P.J., Yachida S., Mudie L.J., et al. The patterns and dynamics of genomic instability in metastatic pancreatic cancer. Nature 2010, 467:1109-1113.
8. Klein C.A. Parallel progression of primary tumors and metastases. Nat Rev Cancer 2009, 9:302-312.
9. Husemann Y., Geigl J.B., Schubert F., et al. Systemic spread is an early step in breast cancer. Cancer Cell 2008, 13:58-68.
10. Rhim A.D., Mirek E.T., Aiello N.M., et al. EMT and dissemination precede pancreatic tumor formation. Cell 2012, 148:349-361.
11. Mehes G., Witt A., Kubista E., Ambros P.F. Circulating breast cancer cells are frequently apoptotic. Am J Pathol 2001, 159:17-20.
12. Saad F., Pantel K. The current role of circulating tumor cells in the diagnosis and management of bone metastases in advanced prostate cancer. Future Oncol 2012, 8:321-331.
13. Fehm T., Solomayer E.F., Meng S., et al. Methods for isolating circulating epithelial cells and criteria for their classification as carcinoma cells. Cytotherapy 2005, 7:171-185.
14. Raimondi C., Gradilone A., Naso G., et al. Epithelial-mesenchymal transition and stemness features in circulating tumor cells from breast cancer patients. Breast Cancer Res Treat 2011, 130:449-455.
15. Ocana O.H., Corcoles R., Fabra A., et al. Metastatic colonization requires the repression of the epithelial-mesenchymal transition inducer prrx1. Cancer Cell 2012, 22:709-724.
16. Joosse S.A., Pantel K. Biologic challenges in the detection of circulating tumor cells. Cancer Res 2013, 73:8-11.
17. Sandri M.T., Zorzino L., Cassatella M.C., et al. Changes in circulating tumor cell detection in patients with localized breast cancer before and after surgery. Ann Surg Oncol 2010, 17:539-545.
18. Nagrath S., Sequist L.V., Maheswaran S., et al. Isolation of rare circulating tumour cells in cancer patients by microchip technology. Nature 2007, 450:1235-1239.
19. Allard W.J., Matera J., Miller M.C., et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004, 10:6897-6904.
20. Zhou J., Hu L., Yu Z., et al. Marker expression in circulating cancer cells of pancreatic cancer patients. J Surg Res 2011, 171:631-636.
21. Tjensvoll K., Nordgardand O., Smaaland R. Circulating tumor cells in pancreatic cancer patients: methods of detection and clinical implications. Int J Cancer 2013, [Epub ahead of print]. 10.1002/ijc.28134.
22. Soeth E., Grigoleit U., Moellmann B., et al. Detection of tumor cell dissemination in pancreatic ductal carcinoma patients by CK 20 RT-PCR indicates poor survival. J Cancer Res Clin Oncol 2005, 131:669-676.
23. Ren C., Han C., Zhang J., et al. Detection of apoptotic circulating tumor cells in advanced pancreatic cancer following 5-fluorouracil chemotherapy. Cancer Biol Ther 2011, 12:700-706.
24. Matsugi S., Hamada T., Shioi N., et al. Serum carboxypeptidase A activity as a biomarker for early-stage pancreatic carcinoma. Clin Chim Acta 2007, 378:147-153.
25. Ren C., Chen H., Han C., et al. Increased plasma microRNA and CD133/CK18-positive cancer cells in the pleural fluid of a pancreatic cancer patient with liver and pleural metastases and correlation with chemoresistance. Oncol Lett 2012, 4:691-694.
26. Goggins M. Molecular markers of early pancreatic cancer. J Clin Oncol 2005, 23:4524-4531.
27. Liu J., Gao J., Du Y., et al. Combination of plasma microRNAs with serum CA19-9 for early detection of pancreatic cancer. Int J Cancer 2012, 131:683-691.
28. Pelaez-Luna M., Takahashi N., Fletcher J.G., Chari S.T. Resectability of presymptomatic pancreatic cancer and its relationship to onset of diabetes: a retrospective review of CT scans and fasting glucose values prior to diagnosis. Am J Gastroenterol 2007, 102:2157-2163.
29. Larson C.J., Moreno J.G., Pienta K.J., et al. Apoptosis of circulating tumor cells in prostate cancer patients. Cytometry A 2004, 62:46-53.
30. Marrinucci D., Bethel K., Lazar D., et al. Cytomorphology of circulating colorectal tumor cells: a small case series. J Oncol 2010, 2010:861341.
31. Katz R.L., He W., Khanna A., et al. Genetically abnormal circulating cells in lung cancer patients: an antigen-independent fluorescence in situ hybridization-based case-control study. Clin Cancer Res 2010, 16:3976-3987.
32. Fehm T., Sagalowsky A., Clifford E., et al. Cytogenetic evidence that circulating epithelial cells in patients with carcinoma are malignant. Clin Cancer Res 2002, 8:2073-2084.
33. Ren C., He P., Zhang J., et al. Malignant characteristics of circulating tumor cells and corresponding primary tumor in a patient with esophageal squamous cell carcinoma before and after surgery. Cancer Biol Ther 2011, 11:633-638.